Results 1 to 10 of about 1,702,896 (192)
Some of the next articles are maybe not open access.

Methylene Blue

Pediatric Emergency Care, 2021
Abstract Methylene blue has been in medicinal use for centuries and is best known as an antidotal treatment for acquired methemoglobinemia (MetHB). More recently, methylene blue has gained recognition for its efficacious use in the treatment of ifosfamide neurotoxicity and refractory vasoplegic shock in both the pediatric and adult critical ...
Renita S, Pushparajah Mak   +1 more
  +9 more sources

Methylene Blue

American Journal of Therapeutics, 2003
Methylene blue finds its major utilization in toxicology in the treatment of methemoglobinemia at a dose of 1 to 2 mg/kg intravenously. By interacting with methemoglobin and the erythrocyte's enzyme systems to reduce back to hemoglobin, methylene blue is a generally safe drug with dose-related hemolytic effects.
Jack, Clifton, Jerrold B, Leikin
openaire   +2 more sources

Methylene Blue

Survey of Anesthesiology, 2016
Methylene blue (MB) has received much attention in the perioperative and critical care literature because of its ability to antagonize the profound vasodilation seen in distributive (also referred to as vasodilatory or vasoplegic) shock states.
Leila, Hosseinian   +3 more
openaire   +3 more sources

Sinography and methylene blue

Journal of the American Podiatric Medical Association, 1987
M, Ayres, I O, Kanat, K, Joshi
openaire   +2 more sources

Teratogen update: Methylene blue?

Teratology, 1999
Methylene blue (MB) is a cationic thiazine dye with the chemical name tetramethylthionine chloride. It has a characteristic deep blue color in the oxidized state, but the reduced form, leukomethylene blue (LMB), is colorless. Methylene blue has been widely used in a variety of clinical settings to identify anatomic (Manhes et al., ’94; Sills and ...
openaire   +2 more sources

Methylene Blue Dye: Toxicity and Potential Elimination Technology From Wastewater

Results in Engineering, 2022
Elizabeth Oyinkansola Omotola   +1 more
exaly  

Home - About - Disclaimer - Privacy